POLICY · STARTUPS · #3476
Voinosis wins DETO 2026 slot to enter TechCrunch Startup Battlefield 200
Nine early-stage South Korean startups pitched at DETO 2026 in Seoul for a place in TechCrunch’s Startup Battlefield 200; Voinosis — which uses AI voice analysis to screen for changes in brain health — won the selection. Other participants include startups across healthcare, fintech, energy, semiconductors and robotics (notable names: Awesome Lab/ThermoFlux, Crosshub/IDBlock, DeepFusion AI, EFLOW, Otition Medical, Riibotics, Ternell/T‑SRAM and Testbank/Solve); several firms plan U.S. expansion.
KEY POINTS
- Nine early-stage South Korean startups pitched at DETO 2026 in Seoul for a place in TechCrunch’s Startup Battlefield 200; Voinosis — which uses AI voice analysis to screen for changes in brain health — won the selection.
- Other participants include startups across healthcare, fintech, energy, semiconductors and robotics (notable names: Awesome Lab/ThermoFlux, Crosshub/IDBlock, DeepFusion AI, EFLOW, Otition Medical, Riibotics, Ternell/T‑SRAM and Testbank/Solve); several firms plan U.S.
- The selection spot gives Voinosis and other Korean deep‑tech startups exposure to TechCrunch’s Disrupt audience and investor networks, potentially accelerating U.S. market entry and fundraising.
WHY IT MATTERS
The selection spot gives Voinosis and other Korean deep‑tech startups exposure to TechCrunch’s Disrupt audience and investor networks, potentially accelerating U.S. market entry and fundraising.